Abstract

Aim: The purpose of the present study was to determine if C-reactive protein (CRP)/albumin ratio was associated with disease severity and unfavorable outcome in patients with aneurysmal subarachnoid hemorrhage (aSAH).Methods: One hundred and twenty-three consecutive patients suffering from aSAH were included in the study, which was carried out during the period of June 2016 to September 2018. Clinical and demographic parameters were recorded. CRP and albumin assessments were conducted upon admission. The association of CRP/albumin ratio with the disease severity and 3-month outcomes was evaluated.Results: Higher CRP/albumin ratio was significantly associated with a higher World Federation of Neurological Surgeons Scale (WFNS) grade (p < 0.05). Poor outcome at 3 months was associated with a higher WFNS grade, higher serum glucose, higher CRP level, lower albumin level, higher Fisher score, higher CRP/albumin ratio, symptomatic cerebral vasospasm, intraventricular hemorrhage, delayed cerebral ischemia, and age using univariate analysis. The multivariate binary regression analysis revealed that the CRP/albumin ratio was independently associated with unfavorable outcomes after adjustment for age, WFNS grade, serum glucose, albumin, Fisher score, symptomatic cerebral vasospasm, intraventricular hemorrhage, and delayed cerebral ischemia.Conclusion: Elevated CRP/albumin ratio was associated with disease severity and poor outcomes after aSAH.

Highlights

  • Aneurysmal subarachnoid hemorrhage is a devastating form of stroke associated with high morbidity and mortality rates [1]

  • The glucose, CRP/Albumin Ratio Reflect aSAH SeverityC-reactive protein (CRP), and CRP/albumin ratio values on admission in patients with poor outcomes at 3 months were significantly higher than the corresponding values in patients with good outcomes (Table 2, p < 0.05)

  • The main results of this study indicated that serum CRP/albumin ratio was associated with the severity of aSAH

Read more

Summary

Introduction

Aneurysmal subarachnoid hemorrhage (aSAH) is a devastating form of stroke associated with high morbidity and mortality rates [1]. Much effort has been directed toward the identification of blood-based biomarkers that are useful in predicting outcomes in aSAH patients [4]. High CRP levels have been studied in relation to prognosis and mortality in aSAH patients [6,7,8]. The CRP/albumin ratio has been established as an independent prognostic marker in patients with infection, malignancy, and critical illness [10,11,12]. The prognostic value of the combined usefulness of CRP and albumin in aSAH has not been evaluated. The aim of this study was to evaluate the correlation of CRP/albumin ratio with severity of disease and outcome in aSAH patients

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call